Kompetitív polimeráz láncreakció

új lehetöség az N-myc amplifikáció mértékének meghatározására.

Translated title of the contribution: Competitive polymerase chain reaction: a new method for measuring N-myc amplification

T. Tornóczky, J. Vass, P. Kajtár, M. Kardos, G. Lendvai, T. Varga, L. Pajor

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

The highly variable biological behaviour of neuroblastoma, a neoplasm which belongs to the family of primitive neuroectodermal tumours, is determined by its molecular pathological characteristics. Among them amplification of the N-myc gene is the most important factor in both therapeutic and prognostic points of view. Value of the amplification can be determined by different methods. The latest of them is the competitive polymerase chain reaction (PCR), essence of which is the parallel reaction of the target N-myc gene (exon 3.) and the endogen competitor CF gene (exon 3.) in the same reaction solution. The authors applied the method on 11 neuroblastoma cases diagnosed between 1994 and january of 1999. In three cases the amplification was determined also by fluorescens in situ hybridization (FISH). Six of the 11 cases were detected to have more than 10-fold, two of the six about 100-fold N-myc amplification. Results of the PCR and FISH correlated well. The two methods applied by the authors complete each other and are appropriate for determining the gene amplification which gives valuable prognostic and therapeutic information about the examined tumour.

Original languageHungarian
Pages (from-to)27-30
Number of pages4
JournalOrvosi Hetilap
Volume141
Issue number1
Publication statusPublished - Jan 2 2000

Fingerprint

myc Genes
Neuroblastoma
Polymerase Chain Reaction
In Situ Hybridization
Exons
Primitive Neuroectodermal Tumors
Gene Amplification
Neoplasms
Therapeutics
Genes

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Tornóczky, T., Vass, J., Kajtár, P., Kardos, M., Lendvai, G., Varga, T., & Pajor, L. (2000). Kompetitív polimeráz láncreakció: új lehetöség az N-myc amplifikáció mértékének meghatározására. Orvosi Hetilap, 141(1), 27-30.

Kompetitív polimeráz láncreakció : új lehetöség az N-myc amplifikáció mértékének meghatározására. / Tornóczky, T.; Vass, J.; Kajtár, P.; Kardos, M.; Lendvai, G.; Varga, T.; Pajor, L.

In: Orvosi Hetilap, Vol. 141, No. 1, 02.01.2000, p. 27-30.

Research output: Contribution to journalArticle

Tornóczky, T, Vass, J, Kajtár, P, Kardos, M, Lendvai, G, Varga, T & Pajor, L 2000, 'Kompetitív polimeráz láncreakció: új lehetöség az N-myc amplifikáció mértékének meghatározására.', Orvosi Hetilap, vol. 141, no. 1, pp. 27-30.
Tornóczky, T. ; Vass, J. ; Kajtár, P. ; Kardos, M. ; Lendvai, G. ; Varga, T. ; Pajor, L. / Kompetitív polimeráz láncreakció : új lehetöség az N-myc amplifikáció mértékének meghatározására. In: Orvosi Hetilap. 2000 ; Vol. 141, No. 1. pp. 27-30.
@article{6301425f905b4f8bb4af758818fbef0d,
title = "Kompetit{\'i}v polimer{\'a}z l{\'a}ncreakci{\'o}: {\'u}j lehet{\"o}s{\'e}g az N-myc amplifik{\'a}ci{\'o} m{\'e}rt{\'e}k{\'e}nek meghat{\'a}roz{\'a}s{\'a}ra.",
abstract = "The highly variable biological behaviour of neuroblastoma, a neoplasm which belongs to the family of primitive neuroectodermal tumours, is determined by its molecular pathological characteristics. Among them amplification of the N-myc gene is the most important factor in both therapeutic and prognostic points of view. Value of the amplification can be determined by different methods. The latest of them is the competitive polymerase chain reaction (PCR), essence of which is the parallel reaction of the target N-myc gene (exon 3.) and the endogen competitor CF gene (exon 3.) in the same reaction solution. The authors applied the method on 11 neuroblastoma cases diagnosed between 1994 and january of 1999. In three cases the amplification was determined also by fluorescens in situ hybridization (FISH). Six of the 11 cases were detected to have more than 10-fold, two of the six about 100-fold N-myc amplification. Results of the PCR and FISH correlated well. The two methods applied by the authors complete each other and are appropriate for determining the gene amplification which gives valuable prognostic and therapeutic information about the examined tumour.",
author = "T. Torn{\'o}czky and J. Vass and P. Kajt{\'a}r and M. Kardos and G. Lendvai and T. Varga and L. Pajor",
year = "2000",
month = "1",
day = "2",
language = "Hungarian",
volume = "141",
pages = "27--30",
journal = "Orvosi Hetilap",
issn = "0030-6002",
publisher = "Akademiai Kiado",
number = "1",

}

TY - JOUR

T1 - Kompetitív polimeráz láncreakció

T2 - új lehetöség az N-myc amplifikáció mértékének meghatározására.

AU - Tornóczky, T.

AU - Vass, J.

AU - Kajtár, P.

AU - Kardos, M.

AU - Lendvai, G.

AU - Varga, T.

AU - Pajor, L.

PY - 2000/1/2

Y1 - 2000/1/2

N2 - The highly variable biological behaviour of neuroblastoma, a neoplasm which belongs to the family of primitive neuroectodermal tumours, is determined by its molecular pathological characteristics. Among them amplification of the N-myc gene is the most important factor in both therapeutic and prognostic points of view. Value of the amplification can be determined by different methods. The latest of them is the competitive polymerase chain reaction (PCR), essence of which is the parallel reaction of the target N-myc gene (exon 3.) and the endogen competitor CF gene (exon 3.) in the same reaction solution. The authors applied the method on 11 neuroblastoma cases diagnosed between 1994 and january of 1999. In three cases the amplification was determined also by fluorescens in situ hybridization (FISH). Six of the 11 cases were detected to have more than 10-fold, two of the six about 100-fold N-myc amplification. Results of the PCR and FISH correlated well. The two methods applied by the authors complete each other and are appropriate for determining the gene amplification which gives valuable prognostic and therapeutic information about the examined tumour.

AB - The highly variable biological behaviour of neuroblastoma, a neoplasm which belongs to the family of primitive neuroectodermal tumours, is determined by its molecular pathological characteristics. Among them amplification of the N-myc gene is the most important factor in both therapeutic and prognostic points of view. Value of the amplification can be determined by different methods. The latest of them is the competitive polymerase chain reaction (PCR), essence of which is the parallel reaction of the target N-myc gene (exon 3.) and the endogen competitor CF gene (exon 3.) in the same reaction solution. The authors applied the method on 11 neuroblastoma cases diagnosed between 1994 and january of 1999. In three cases the amplification was determined also by fluorescens in situ hybridization (FISH). Six of the 11 cases were detected to have more than 10-fold, two of the six about 100-fold N-myc amplification. Results of the PCR and FISH correlated well. The two methods applied by the authors complete each other and are appropriate for determining the gene amplification which gives valuable prognostic and therapeutic information about the examined tumour.

UR - http://www.scopus.com/inward/record.url?scp=0034594372&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034594372&partnerID=8YFLogxK

M3 - Article

VL - 141

SP - 27

EP - 30

JO - Orvosi Hetilap

JF - Orvosi Hetilap

SN - 0030-6002

IS - 1

ER -